Global Immune Thrombocytopenia Market by Type (Acute Immune Thrombocytopenia, and Chronic Immune Thrombocytopenia), By Treatment (Intravenous Immunoglobulins, Corticosteroids, and Thrombopoietin Receptor Agonists), By End-User (Hospitals and Clinics, Specialty Centers, and Research and Academic Institutes), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032
- Published date: Oct 2023
- Report ID: 102400
- Number of Pages: 322
- Format:
-
-
-
- Pfizer Inc Company Profile
- Hoffmann-La Roche Ltd
- Mylan N.V.
- Fresenius Kabi AG
- Hikma Pharmaceuticals PLC
- Hepalink Group.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Amarillo Biosciences Inc
- Bolder Bio Technology Inc.
- GENOSCO Inc.
- Hansa Biopharma
- Janssen Pharmaceuticals Inc.
- Eisai Co Ltd
- CSL Limited
- Amgen Inc.
- Kyowa Hakko Kirin Co. Ltd.
- Rigel Pharmaceuticals Inc.
- Shionogi Inc.
- Dova Pharmaceuticals
- Novartis AG Company Profile
- Jiangsu Hengrui Pharmaceutical Co. Ltd.
- Shire and Ligand Pharmaceuticals Inc.
- Other Key Players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible